One week after intracranial inoculation, tumor growth was confirmed by in vivo bioluminescence imaging, and then mice were randomized into four treatment groups: Untreated, LB-100, anti-CAIX CAR-T, and Combo (LB-100 plus anti-CAIX CAR-T) groups. Here, CA9 is linked to neoplasm.